MedPath

MUNDIPHARMA PHARMACEUTICALS SRL

🇮🇹Italy
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 3
1 (100.0%)

Trauma Acute Pain Treatment With Methoxyflurane Vaporized (PENTHROX®): Efficacy and Safety Study (MEDITA)

Phase 3
Completed
Conditions
Acute Traumatic Pain
Interventions
Combination Product: Methoxyflurane and Penthrox inhaler
First Posted Date
2018-07-13
Last Posted Date
2019-05-09
Lead Sponsor
Mundipharma Pharmaceuticals srl
Target Recruit Count
272
Registration Number
NCT03585374
Locations
🇮🇹

AO Universitaria- Policlinico V.Emanuele Medicina e Chirurgia d'Accettazione e d'Urgenza, Catania, CT, Italy

🇮🇹

AO per l'Emergenza- Cannizzaro UO Servizio di Urgenza Emergenza Sanitaria 118, Catania, CT, Italy

🇮🇹

Medicina D'Urgenza ed Accettazione Azienda Ospedaliera di Catanzaro "Pugliese-Ciaccio", Catanzaro, CZ, Italy

and more 13 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.